Australia Patent: ImmunityBio, Institute for Cancer Research D/B/A The Research Institute of Fox Chase Cancer Center File Application for 'Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer'

Press/Media

PeriodNov 16 2023

Media coverage

1

Media coverage

  • TitleAustralia Patent: ImmunityBio, Institute for Cancer Research D/B/A The Research Institute of Fox Chase Cancer Center File Application for 'Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date11/16/23
    PersonsKerry S. Campbell